27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

RZLT Insider Trading (Rezolute)

Insider Ownership Percentage: 28.10%
Insider Buying (Last 12 Months): $10,279,995.22
Insider Selling (Last 12 Months): $0.00

Rezolute Insider Trading History Chart

This chart shows the insider buying and selling history at Rezolute by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rezolute Share Price & Price History

Current Price: $3.52
Price Change: Price Increase of +0.07 (2.03%)
As of 05/16/2022 03:31 PM ET

This chart shows the closing price history over time for RZLT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
High Arch Potential Stock
If you're looking for a hot new sector, watch this stock closely.
Click for ticker & full details

Rezolute Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/4/2022Brian Kenneth RobertsSVPBuy21,052$3.80$79,997.6021,052View SEC Filing Icon  
5/4/2022Gil M LabrucherieDirectorBuy52,631$3.80$199,997.8052,631View SEC Filing Icon  
7/23/2021Genexine Inc.Major ShareholderBuy34,482,758$0.29$9,999,999.82View SEC Filing Icon  
9/24/2020Handok, Inc.Major ShareholderBuy250,000$0.45$112,500.00
9/22/2020Handok, Inc.Major ShareholderBuy250,000$0.46$115,000.00
9/18/2020Handok, Inc.Major ShareholderBuy125,000$0.46$57,500.00
9/9/2020Handok, Inc.Major ShareholderBuy250,000$0.47$117,500.00
9/1/2020Handok, Inc.Major ShareholderBuy250,000$0.52$130,000.00
8/27/2020Handok, Inc.Major ShareholderBuy250,000$0.47$117,500.00
8/25/2020Handok, Inc.Major ShareholderBuy250,000$0.50$125,000.00
8/4/2020Handok, Inc.Major ShareholderBuy125,000$0.34$42,500.00
7/31/2020Handok, Inc.Major ShareholderBuy375,000$0.32$120,000.00
7/16/2020Handok, Inc.Major ShareholderBuy250,000$0.19$47,500.00
7/14/2020Handok, Inc.Major ShareholderBuy84,000$0.16$13,440.00
See Full Table
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

SEC Filings (Institutional Ownership Changes) for Rezolute (NASDAQ:RZLT)

48.42% of Rezolute stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RZLT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Rezolute Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022State Street Corp20,300$69K0.0%N/A0.130%Search for SEC Filing on Google Icon
5/16/2022J. Goldman & Co LP54,000$0.18M0.0%-73.3%0.347%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.343,739$1.16M0.0%+3.2%2.209%Search for SEC Filing on Google Icon
5/12/2022AIGH Capital Management LLC420,913$1.42M0.3%+58.7%2.706%Search for SEC Filing on Google Icon
5/10/2022Provence Wealth Management Group20,000$68K0.1%N/A0.129%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.19,583$94K0.0%+60.9%0.126%Search for SEC Filing on Google Icon
2/15/2022Sender Co & Partners Inc.81,849$0.39M0.2%N/A0.530%Search for SEC Filing on Google Icon
2/15/2022Shay Capital LLC11,780$56K0.0%N/A0.076%Search for SEC Filing on Google Icon
2/15/2022Stonepine Capital Management LLC808,405$3.86M1.8%N/A5.236%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC20,571$98K0.0%-42.4%0.133%Search for SEC Filing on Google Icon
2/14/2022Maven Securities LTD115,758$0.55M0.0%N/A0.750%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC265,181$1.27M0.4%N/A1.717%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp52,293$0.25M0.0%+45.7%0.339%Search for SEC Filing on Google Icon
11/17/2021Altium Capital Management LP230,000$1.55M0.3%N/A2.668%Search for SEC Filing on Google Icon
11/16/2021UBS Group AG3,671$27K0.0%+299.9%0.043%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC35,712$0.27M0.0%N/A0.414%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC309,986$2.30M0.0%+0.6%3.596%Search for SEC Filing on Google Icon
11/12/2021Oppenheimer & Co. Inc.12,281$92K0.0%N/A0.142%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC307,988$4.40M0.0%-1.4%3.688%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp32,124$0.46M0.0%N/A0.385%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.29,390$0.42M0.0%N/A0.352%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC26,924$0.19M0.0%N/A0.322%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC312,336$2.21M0.0%+2.7%3.740%Search for SEC Filing on Google Icon
5/17/2021Armistice Capital LLC288,000$2.03M0.0%-13.8%3.448%Search for SEC Filing on Google Icon
5/17/2021683 Capital Management LLC18,916$0.13M0.0%-52.7%0.226%Search for SEC Filing on Google Icon
2/16/2021Armistice Capital LLC333,990$4.01M0.1%N/A3.999%Search for SEC Filing on Google Icon
2/16/2021Caxton Corp424,243$5.09M3.2%N/A5.080%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.1,212,122$14.53M0.0%N/A14.513%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Rezolute logo
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Read More on Rezolute

Today's Range

Now: $3.52
Low: $3.40
High: $3.55

50 Day Range

MA: $3.43
Low: $2.27
High: $4.10

52 Week Range

Now: $3.52
Low: $2.26
High: $17.39


715 shs

Average Volume

156,521 shs

Market Capitalization

$54.76 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Rezolute?

Rezolute's top insider shareholders include:
  1. Gil M Labrucherie (Director)
  2. Brian Kenneth Roberts (SVP)
  3. Genexine Inc (Major Shareholder)
  4. Handok, Inc (Major Shareholder)
Learn More about top insider investors at Rezolute.

Who are the major institutional investors of Rezolute?

Rezolute's top institutional shareholders include:
  1. AIGH Capital Management LLC — 2.71%
  2. Vanguard Group Inc. — 2.21%
  3. J. Goldman & Co LP — 0.35%
  4. State Street Corp — 0.13%
  5. Provence Wealth Management Group — 0.13%
Learn More about top institutional investors of Rezolute stock.

Which institutional investors are selling Rezolute stock?

During the last quarter, RZLT stock was sold by these institutional investors:
  1. J. Goldman & Co LP

Which institutional investors are buying Rezolute stock?

In the previous quarter, RZLT stock was bought by institutional investors including:
  1. AIGH Capital Management LLC
  2. State Street Corp
  3. Provence Wealth Management Group
  4. Vanguard Group Inc.
During the last year, these company insiders have bought Rezolute stock:
  1. Gil M Labrucherie (Director)
  2. Brian Kenneth Roberts (SVP)
  3. Genexine Inc (Major Shareholder)
  4. Handok, Inc (Major Shareholder)
Learn More investors buying Rezolute stock.
Bargain in Today's Market (SHOCKING)
This "World's Most Admired" company's stock would be a bargain at $50...Today it's just $2! Plus... a key May 12 announcement could send it ROCKETING skyward...

Click Here Now (Before It's Too Late!)